Skip Navigation LinksHome > Professional Development > eLearning > Zika Virus: Donor Screening and Handling CT Products in the Face of Emerging Viruses

Zika Virus: Donor Screening and Handling CT Products in the Face of Emerging Viruses

Please note: AABB reserves the right to make updates to this program.                          

Live Program: Thursday, September 21, 2017 - On-Demand Available

Master Program Number: 17EL-160 (see program format numbers below under Registration)

Educational Track: Technical/Clinical 
Topic: Cellular Therapies
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, Donor Recruitment Staff
Teaching Level: Basic-Intermediate

Director/Moderator: Deborah Sesok-Pizzini, MD, MBA, Vice-Chief, Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA
Speakers: Tina S. Ipe, MD, MPH, Associate Medical Director, Transfusion Medicine, Houston Methodist Hospital, Houston, TX; Abba C. Zubair, MD, PhD, Medical Director, Transfusion Medicine and Stem Cell Therapy, Associate Professor of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Discuss updates on Zika virus testing and donor screening for cellular therapy products.
  • Identify the handling of products potentially infected with Zika virus and the implications for using these products.
  • Discuss current regulations on Zika virus testing as it applies to cellular therapy products.
  • Describe the incidence and risk of Zika virus transmission in the United States.

Program Description

Newly emerging viruses, such as Zika virus, are a threat to the blood supply as well as autologous and allogenic cellular therapy products collected for use in transplants.  Understanding the risk of Zika virus transmission, current donor testing and screening, and the regulations which help to prevent transmission are critical for patients undergoing cellular therapeutic procedures.  The presenters will discuss current strategies used in collection facilities and stem cell laboratories to help mitigate the Zika virus outbreak.    

Registration

   Program #
Single Viewer: On-Demand Register17EL-4070-160
Group Viewing: On-Demand Register17EL-8070-160

Speaker Biographies

Dr. Abba Zubair is currently the Medical Director of Transfusion Medicine at Mayo Clinic Florida and Associate Professor at Mayo Clinic College of Medicine. Dr. Zubair is a certified international inspector of bone marrow transplant centers and blood banks for the Foundation for the Accreditation of Cellular Therapy and the AABB. Dr. Zubair did his clinical residency at the Hospital of University of Pennsylvania in Clinical Pathology and a fellowship in Transfusion Medicine at the Joint Program in Transfusion Medicine, Harvard Medical Center, Boston USA. Dr. Zubair studied homing and trafficking of human lymphoma cells at Sheffield University Cancer Institute, England and obtained a PhD degree in Cancer Immunobiology from the institute in 1995. He also has a master’s degree in Clinical trials and principles of drug development at Harvard University and MIT. His research interest is in the field of stem cell biology. He currently conducts both NIH and industry-sponsored basic science and clinical studies on stem cells.

Dr. Tina Ipe bio to be provided.